Back to Tools
Iktos vs Generate Biomedicines
Side-by-side comparison of features, pricing, and ratings
End-to-end autonomous drug discovery platform integrating generative AI with robotic synthesis and testing.
Visit Website
Generative AI platform for protein-based drug discovery and design.
Visit WebsitePricing
Contact Sales
Contact Sales
Plans
—
—
Popularity
5.5k views
5.9k views
Skill Level
Advanced
Advanced
API Available
Platforms
WebAPI
—
Categories
🤖 Automation & Agents🏥 Healthcare
📊 Data & Analytics🔬 Research & Education🏥 Healthcare
Features
Chemistry-first generative AI for de novo molecular design
Multi-parametric optimization (potency, ADME, toxicity)
3D constraint inclusion (protein-ligand interactions)
AI-driven retrosynthesis planning (Spaya)
Real-time retrosynthetic route display
Customizable synthesis steps and constraints
Fully automated synthesis, purification, analysis
High-throughput data generation and iteration
In-cellulo biological screening integration
Support for PPI, RNA-protein, molecular glues, PROTACs
Iktos Engine APIs for agentic workflows (May 2026)
Automated ordering of raw materials
Workflow management for DMTA cycles
Generative protein design using machine learning
Real-time feedback loop between computation and biology
42,000+ proteins generated, built, and tested
Multi-modality therapeutic generation
Generative Biology platform for drug discovery
Phase 3 clinical program (GB-0895 for asthma)
Learned rules of protein function from millions of proteins
On-demand creation of novel medicines
Integrated human insight at every layer
Continuous experimentation and model refinement
Integrations
Chemspeed (automated chemical research, announced March 2026)
Various data providers for retrosynthesis (via Spaya)